AI assistant
Sending…
STAAR SURGICAL CO — Director's Dealing 2020
May 16, 2020
31996_dirs_2020-05-15_36d5b950-9d17-4eb2-b88b-a991122f7ee4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2020-05-15
Reporting Person: Holliday Keith (Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-15 | Common Stock | M | 25000 | $7.20 | Acquired | 53447 | Direct |
| 2020-05-15 | Common Stock | S | 25000 | $37.69 | Disposed | 28447 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-05-15 | Common Stock Options | $7.20 | M | 25000 | Disposed | 2025-08-18 | Common Stock (25000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.52 to $37.88, inclusive.
More from STAAR SURGICAL CO
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
May 12
Annual Report
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 20
Regulatory Filings
2026
Apr 8
Major Shareholding Notification
2026
Mar 27